Alteration of SREBP activation in liver of trisomy 21 fetuses

Citation
L. Diomede et al., Alteration of SREBP activation in liver of trisomy 21 fetuses, BIOC BIOP R, 260(2), 1999, pp. 499-503
Citations number
29
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
260
Issue
2
Year of publication
1999
Pages
499 - 503
Database
ISI
SICI code
0006-291X(19990705)260:2<499:AOSAIL>2.0.ZU;2-X
Abstract
We previously reported that trisomy 21 (T21) fetuses have an intrinsic lipi d metabolism abnormality resulting in higher serum cholesterol levels than their matched controls. In an attempt to clarify the biochemical basis of t his derangement we analyzed the liver cholesterol levels and activation of the sterol regulatory element binding proteins SREBP-1 and SREBP-2. We repo rt here for the first time that SREBP-1 and SREBP-2 are present in human fe tal liver and their activation follows a different regulatory pattern. More over T21 fetuses show a peculiar pattern of SREBP activation which, at vari ance from control fetuses, involves sterol-independent maturation of SREBP- 1. Multiple defects accompanied the lipid derangement in T21, resulting in high circulating and tissue cholesterol. This may serve as an early biochem ical marker of an unknown, possibly genetically determined mechanism, whose consequence on lipid homeostasis during postnatal and adult life is still not understood. (C) 1999 Academic Press.